Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 101 - 110 of 202 for excel. (0.16 seconds)

AlphaRx signed a long-term contract manufacturing...
Pharmaron Holdings Limited has completed its acquisition...
OrbusNeich has enrolled the first patient in a China...
WuXi PharmaTech (药明康德), continuing the string of...
Venturepharm Laboratory said it signed a letter of intent...
The spectacular IPO of Sinopharm Group in September 2009...
WuXi PharmaTech reported impressive Q3 results, showing...
Novo Nordisk will spend up to $100 million to expand its...
PPD, Inc. announced a joint venture that will extend the...
Xu Tian, PhD, is an accomplished China transplant with...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here